UNSPSC 51343511: Tenofovir disoproxil

This classification denotes a reverse transcriptase inhibitor and purine antagonist C19H30N5O10P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F4YU4LON7I, chemically known as 2,4,6,8-tetraoxa-5-phosphanonanedioic acid, 5-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, 1,9-bis(1-methylethyl) ester, 5-oxide, but more generally known as tenofovir disoproxil, which bears US NIH Compound Identifier 5481350.

UNSPSC 51343511 Tenofovir disoproxil, a Commodity code, shows minimal relevant recent activity in state and local procurement. The four recent opportunities tagged under this code address naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer pharmacy prescriptions (Texas HHS Commission), medical and first aid supplies for fire rescue (City of Tampa), and generic multi-source pharmaceuticals through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations involve tenofovir disoproxil, an antiretroviral medication used in HIV treatment. The code itself appears misapplied to these procurements, which span emergency response supplies, pharmacy benefit program design, and broad-based OTC and generic pharmaceutical contracting rather than a specific pharmaceutical product.

State and local governments do not appear to be soliciting tenofovir disoproxil as a distinct line item under this code at present. The recent opportunities represent procurement activity across state health agencies, county health departments, municipal emergency services, and cooperative purchasing vehicles, but none target antiretroviral pharmaceuticals. If your firm supplies tenofovir disoproxil to state Medicaid programs, correctional health systems, or public health departments, monitor state health agency RFPs and cooperative purchasing alliance solicitations for pharmaceutical contracting; the current code record does not reflect active demand for this product specifically.